skip navigation

LIBRARY

Abstract Database

Register for Latest Research

Stay Informed
Register with NCJRS to receive NCJRS's biweekly e-newsletter JUSTINFO and additional periodic emails from NCJRS and the NCJRS federal sponsors that highlight the latest research published or sponsored by the Office of Justice Programs.

NCJRS Abstract

To download this abstract, check the box next to the NCJ number then click the "Back To Search Results" link. Then, click the "Download" button on the Search Results page. Also see the Obtain Documents page for direction on how to access resources online, via mail, through interlibrary loans, or in a local library.

 

NCJ Number: 249855 Find in a Library
Title: Characterization of Designer Drugs: Chemical Stability, Exposure, and Metabolite Identification, Final Summary Overview and Appendix
Author(s): Megan Grabenauer; Katherine N. Moore; Brian F. Thomas
Date Published: April 2016
Page Count: 53
Sponsoring Agency: National Institute of Justice (NIJ)
Washington, DC 20531
US Dept of Justice NIJ Pub
Washington, DC 20531
Grant Number: 2012-R2-CX-K001
Sale Source: US Dept of Justice NIJ Pub
810 Seventh Street, NW
Washington, DC 20531
United States of America
Document: PDF
Type: Report (Grant Sponsored); Report (Study/Research); Report (Technical); Research (Applied/Empirical)
Format: Document; Document (Online)
Language: English
Country: United States of America
Annotation: The goals of this research were to determine the stability of currently popular designer drugs and identify major degradation products, including pyrolysis products, as well as to identify their major metabolites.
Abstract: Currently, little is known about the pharmacological and toxicological profiles of designer drugs such as synthetic cannabinoids and cathinones. The consequences of their long-term use have yet to be studied; and behavioral and metabolic studies have been performed on a limited number of compounds. The detection of these designer drugs is challenging, because bans on specific compounds result in the drug manufacturers’ rapid substitution of closely related analogs. The current project initially focused on compounds from the JWH and AM series of synthetic cannabinoids and then expanded to include emerging designer drugs as they became prevalent. The research identified metabolites suitable as potential markers of the degradation products and pyrolysis products that may be left in an ash residue. The latter can be used for confirmation of the presence of parent compound. The dataset is extensive and is a reliable starting point for forensic laboratories to develop assays for detection of use and as confirmation of the presence of parent compound within residues. Although new designer drugs continue to enter the market, within each class of designer drugs the elements of chemical structure and design often follow known or rational substitution patterns required to enhance or retain pharmacological activity. A thorough and systematic study of families of structurally related compounds enables the prediction of markers for broad classes of compounds. Project methodology is described in detail. Appended list of eight conference presentations with detailed results
Main Term(s): Forensic sciences
Index Term(s): Designer drugs; Drug analysis; Drug detection; Drug effects; Drug testing; NIJ final report; NIJ Resources
To cite this abstract, use the following link:
http://www.ncjrs.gov/App/publications/abstract.aspx?ID=272015

*A link to the full-text document is provided whenever possible. For documents not available online, a link to the publisher's website is provided. Tell us how you use the NCJRS Library and Abstracts Database - send us your feedback.